EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent - European Urology
Prostate Cancer - INTRODUCTION - Uroweb
Oligometastatic cancer: Total Eradication Treatment TET) Trials — Cancer Ecology Center
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data - The Lancet
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Prostate Cancer - TREATMENT - Uroweb
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023 in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 12 (2022)
The Current State of Treatment Implementation for mCRPC in North America
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer—Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial - ScienceDirect
Frontiers | From Therapy Resistance to Targeted Therapies in Prostate Cancer
Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort | British Journal of Cancer
Frontiers | Prostate Cancer Theranostics - An Overview
Adjuvant Chemotherapy Improves Prostate Cancer Survival - NCI
The Current Landscape of Metastatic Hormone Sensitive Prostate Cancer: A Plethora of Treatment Options
Full article: Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14)
Cancers | Free Full-Text | Management of Advanced Prostate Cancer in the Precision Oncology Era
View of Combination Treatment Options for Castration-Resistant Prostate Cancer | Exon Publications
Guidelines for radiotherapy of prostate cancer (2020 edition) - Li - 2021 - Precision Radiation Oncology - Wiley Online Library
Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions | American Society of Clinical Oncology Educational Book
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial - The Lancet
Progress in therapy across the spectrum of advanced prostate cancer | Nature Reviews Urology
Diagnostics | Free Full-Text | Diagnostic Strategies for Treatment Selection in Advanced Prostate Cancer
